Skip to content

Investiagtion of hormonal aspects of synaptic plasticity using a human surrogate model for central sensitization

Investiagtion of hormonal aspects of synaptic plasticity using a human surrogate model for central sensitization - Gender-LTP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012301
Enrollment
36
Registered
2017-04-27
Start date
2012-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Group 1: After bilateral baseline (BASE) testing twice by the mechanical test stimuli special electrodes were fixed on both ventral forearms to determine the electrical detection threshold. Afterwards

Sponsors

Klinik für Anästhesiologie, Operative Intensivmedizin und Schmerztherapie Universitätsklinikum Münster
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: voluntariness, age 18 - 40 years, regular menstrual cycle varying from 26 to 30 days

Exclusion criteria

Exclusion criteria: pregnancy, lactation, any medication (e. g. hormonal contraceptives, homones, anabolic steroids, analgesic, antidepressants), any pre-existing medical conditions (e.g. diabetes, migraine, multiple sclerosis, psychiatric disorder) or withdrawal of consent

Design outcomes

Primary

MeasureTime frame
Baseline measurement: mechanical pain threshold (with PinPrick; MPT), mechanical pain sensibility (MPS), electrical pain sensibility (EPS), electrical detection threshold (EDT) T0: immediatley after high frequency stimulation (HFS): MPT, MPS, EPS, EDT T1: 1 hour after HFS: MPT, MPS, EPS, EDT T3: three hours after HFS: MPT, MPS, EPS, EDT plus blood sampling T27: 27 hours after HFS: MPT, MPS, EPS, EDT Three measurements: follicular phase, late follicukar phase, luteal phase High levles of progesterone (luteal phase) might amplify an induced primary and/ or secondary hyperalgesia. High levels of estrogen (late follicular phase) might decrease induced hyperalgesia.

Secondary

MeasureTime frame
Measurement for area of hyperalgesia using a brush T0; T1; T3; T27. Regression analysis might detect different gonodal hormones constellations that cause hyperalgesia.

Countries

Germany

Contacts

Public ContactChristine Meyer-Frießem

Klinik für Anästhesiologie, Intensiv-, Palliativ- und Schmerzmedizin; Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum

meyer-friessem@ains-bergmannshei.de0049234-3020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026